IP Library Granted Patent US 10,125,149
Granted Patent B2
US 10,125,149 · App. 15/503,907 · Granted Nov 13, 2018

Synthesis of cephalosporin compounds

Inventors: David Waller (Somerville, MA); Gregory Gazda (Sudbury, MA); Zachary Minden (Watsonville, CA); Lisa Barton (Haverhill, MA); Clifton Leigh (Windham, NH)
Assignee: Merck Sharp & Dohme Corp.
C07D501/56C07D501/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,125,149
App. No.
15/503,907
Granted
Nov 13, 2018
Kind
B2
Abstract

Provided herein is a method for the synthesis of cephalosporin antibiotic compounds comprising a palladium-catalyzed coupling reaction. Provided herein are methods for the synthesis of cephalosporin compounds of formula (I) employing a palladium-catalyzed alkylation reaction, as well as compositions related to the same. In an aspect, provided herein is a method for preparing a compound of formula (II), or a salt thereof, comprising the step of admixing, e.g., reacting, a compound of formula (III), or a salt thereof, with a nucleophile (Nuc) in the presence of reagents comprising: (a) a palladium source; and (b) a palladium-binding ligand, to form a compound of formula (II), or a salt thereof.

Claims (17)

1. A composition comprising a compound of formula (Va):

and from about 0.01 ppm to about 5 ppm palladium,

wherein A ⊖ is a pharmaceutically acceptable anion selected from chloride, bromide, iodide, sulfate, bisulfate, toluenesulfonate, methanesulfonate, edisylate, maleate, phosphate, ketoglutarate, acetate, trifluoroacetate, and trifluoromethanesulfonate.

2. The composition of claim 1 , which comprises from about 0.01 ppm to about 3 ppm palladium.

3. The composition of claim 1 , which comprises from about 0.01 ppm to about 2 ppm palladium.

4. The composition of claim 1 , which comprises from about 0.01 ppm to about 1 ppm palladium.

5. The composition of claim 1 , wherein A ⊖ is chloride.

6. The composition of claim 1 , wherein A ⊖ is bisulfate.

7. The composition of claim 1 , wherein A ⊖ is acetate.

8. The composition of claim 1 , wherein A ⊖ is trifluoroacetate.

9. A composition comprising a compound of formula (VII):

and from about 0.01 ppm to about 5 ppm palladium.

10. The composition of claim 9 , which comprises from about 0.01 ppm to about 3 ppm palladium.

11. The composition of claim 9 , which comprises from about 0.01 ppm to about 2 ppm palladium.

12. The composition of claim 9 , which comprises from about 0.01 ppm to about 1 ppm palladium.

13. A composition comprising a compound of formula (VII):

and from about 0.01 ppm to about 1 ppm palladium.

Assignments (5)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2017
From: GAZDA, GREGORY; MINDEN, ZACHARY; BARTON, LISA
To: CUBIST PHARMACEUTICALS LLC
Reel/Frame 041353/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2017
From: WALLER, DAVID; LEIGH, CLIFTON
To: MERCK SHARP & DOHME CORP.
Reel/Frame 041353/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2017
From: CUBIST PHARMACEUTICALS LLC
To: CALIXA THERAPEUTICS, INC
Reel/Frame 041353/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2017
From: CALIXA THERAPEUTICS, INC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 041353/0724 →
Continuity (4)
Provisional Application 62037676 · Aug 15, 2014
Provisional Application 62065993 · Oct 20, 2014
Provisional Application 62111840 · Feb 4, 2015
Related Publication 20170275300A1 · Sep 28, 2017